- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
PAPER OF THE WEEK: When Patients With Kidney Failure Still Don't Take Medication
The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health
Welcome to Paper of the Week, which looks back at research and commentary from the past 25 years in The American Journal of Managed Care®, and why they matter today.
This week’s paper, “Medication Noncompliance in Patients With Chronic Disease: Issues in Dialysis and Renal Transplantation,” examines the problems with patients who must undergo a kidney transplant but still don’t stick with basic medication regimens for conditions like hypertension, which add to their medical challenges.
The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health.
This week, CMS offered a proposal for helping patients with end-stage renal disease enroll in Medicare Advantage, which complement payment models for renal treatment called Kidney Care First. Overall, the current initiatives in CMS are designed to make nephrologists, dialysis centers, and others involved in renal care more accountable for patients’ overall health.
For the Paper of the Week, visit ajmc.com.
For more about Kidney Care First, see ajmc.com.
Long-Term Benefits Show the Value of Upfront Investments in Value-Based Care
October 17th 2024Miriam Godwin, CMMI, National Kidney Foundation, touches on the gaps in kidney care that public policy can address, as well as the importance of thinking about the long-term benefits of value-based care.
Read More
More Needs to Be Done to Reduce Racial Disparities in Home Dialysis
March 24th 2023On this episode of Managed Care Cast, we speak with Virginia Wang, PhD, and Matthew L. Maciejewski, PhD, who talk about their recent study on racial disparities in home dialysis, and what more needs to be done to increase uptake and reduce disparities in home dialysis for non-White patients.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
